Clinical Pharmacogenetics of Methotrexate
Pasqualina Castaldo(Marche Polytechnic University), Salvatore Amoroso(Azienda Ospedaliero-Universitaria delle Marche), M. Tocchini, Nicola Alesi(Brigham and Women's Hospital), Simona Magi, Vincenzo Lariccia, Sara Arcangeli, Annamaria Assunta Nasti
Cited by 25
Related Papers
Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development
|PLoS Genetics|2016|130
TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism
|Nature Communications|2021|102
TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti–PD-1/anti–CTLA-4 immunotherapy
|JCI Insight|2018|74
p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis
|Cancer Research|2017|65
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
|Nature Communications|2024|46